Drugs / Pantoprazol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01608750 | Jun → Dec 2012 | dyspepsia | Bezmialem Vakif University | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT07032883 Background | Jun 2025 → Feb 2026 overdue | female breast carcinoma | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT01410409 Comparator | Sep 2011 → Mar 2015 | osteoarthritis, knee | Northern Orthopaedic Division, Denmark | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pantoprazol | “Zurcal 40 mg IV (pantoprazol) then followed by oral zurcal tablets.” NCT07032883 ↗ |
| Known as | Zurcal | “Zurcal 40 mg IV (pantoprazol) then followed by oral zurcal tablets.” NCT07032883 ↗ |
| Route | Oral | “40mg/day, oral, 28 days” NCT01608750 ↗ |